T-B cell interaction inhibits spontaneous apoptosis of mature lymphocytes in Bcl-2-deficient mice

Journal of Experimental Medicine

Volumn 182, Issue 4, 1995, Pages 1101-1110

  Nakayama, Kei Ichi ^a,b   Nakayama, Keiko ^a,b   Dustin, Lynn B ^a   Loh, Dennis Y ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NIPPON ROCHE RESEARCH CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; INTERLEUKIN 4;

ANIMAL CELL; ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL MATURATION; CELL SURVIVAL; ETIOLOGY; LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMAL; ANTIGENS, CD3; ANTIGENS, CD40; APOPTOSIS; B-LYMPHOCYTES; CELL COMMUNICATION; CELLS, CULTURED; FLOW CYTOMETRY; IMMUNOGLOBULINS; INTERLEUKIN-4; MICE; MICE, MUTANT STRAINS; MICE, TRANSGENIC; MODELS, IMMUNOLOGICAL; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, ANTIGEN, T-CELL; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES;

EID: 0029149860     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.182.4.1101     Document Type: Article

References (56)

1. Ellis, R.E., J.Y. Yuan, and H.R. Horvitz. 1992. Mechanisms and functions of cell death. Annu. Rev. Cell Biol. 7: 663-698.
2. Williams, G.T., and C.A. Smith. 1993. Molecular regulation of apoptosis: genetic controls on cell death. Cell. 74: 777-779.
3. Vaux, D.L. 1993. Toward an understanding of the molecular mechanisms of physiological cell death. Proc. Natl. Acad. Sci. USA. 90: 786-789.
4. Vaux, D.L., S. Cory, and J.M. Adams. 1988. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature (Lond.). 335: 440-442.
5. Nunez, G., L. London, D. Hockenbery, M. Alexander, J.P. McKeam, and S.J. Korsmeyer 1990. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J. Immunol. 144: 3602-3610.
6. Hockenbery, D.M., M. Zutter, W. Hickey, M. Nahm, and S.J. Korsmeyer. 1991. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc. Natl. Acad. Sci. USA. 88: 6961-6965.
7. Merry, D.E., D. Veis, W.F. Hickey, and S.J. Korsmeyer. 1994. bcl-2 protein expression is widespread in the developing nervous system and retained in the adult PNS. Development (Camb.). 120: 301-311.
8. Gratiot-Deans, J., L. Ding, L.A. Turka, and G. Nunez. 1993. bcl-2 proto-oncogene expression during human T cell development.J. Immunol. 151: 83-91.
9. Veis, D.J., C.L. Sentman, E.A. Bach, and S.J. Korsmeyer. 1993. Expression of the Bcl-2 protein in murine and human thymocytes and in peripheral T cells. J. Immunol. 151: 2546-2554.
10. Merino, R., L. Ding, D. Veis, S.J. Korsmeyer, and G. Nunez. 1994. Developmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytes. EMBO (Eur. Mol. Biol. Organ.) J. 13: 683-691.
11. Liu, Y.-J., D.Y. Mason, G.D. Johnson, S. Abbot, C.D. Gregory, D.L. Hardie, J. Gordon, and C.M. MacLennan. 1991. Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur.J. Immunol. 21: 1905-1910.
12. Pettersson, M., H. Jemberg-Wiklund, L.-G. Larsson, C. Sundstrom, I. Givol, Y. Tsujimoto, and K. Nilsson. 1992. Expression of the bcl-2 gene in human multiple myeloma cell lines and normal plasma cells. Blood. 79: 495-502.
13. Pascual, V., Y.-J. Liu, A. Magalski, O. De Bouteiller, J. Banchereau, and J.D. Capra. 1994. Analysis of somatic mutation in five B cell subsets ofhuman tonsil. J. Exp. Med. 180: 329-339.
14. Liu, Y.-J., D.E. Joshua, G.T. Williams, C.A. Smith, J. Gordon, and C.M. MacLennan. 1989. Mechanism of antigen-driven selection in germinal centres. Nature (Lond.). 342: 929-931.
15. + ligand is independent of Bcl-2 induction. Eur.J. Immunol. 23: 2368-2371.
16. Nakayama, K.-I., K. Nakayama, I. Negishi, K. Kuida, Y. Shinkai, M.C. Louie, L.E. Fields, P.J. Lucas, V. Stewart, F.W. Alt, and D.Y. Loh. 1993. Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice. Science (Wash. DC). 261: 1584-1588.
17. Nakayama, K., K.-I. Nakayama, I. Negishi, K. Kuida, H. Sawa, and D.Y. Loh. 1994. Targeted disruption ofBcl-2a(3 in mice: occurrence of gray hair, polycystic kidney disease, and lymphocytopenia. Proc. Natl. Acad. Sci. USA. 91: 37003704.
18. Veis, D.J., C.M. Sorenson, J.R. Shutter, and S.J. Korsmeyer. 1993. Bcl-2-defident mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell. 75: 229-240.
19. + TCRlc thymocytes in vivo. Science (Wash. DC). 250: 1720-1723.
20. Dustin, L.B., E.D. Bullock, Y. Hamada, T. Azuma, and D.Y. Loh. 1995. Antigen-driven differentiation of naive, immunoglobulin transgenic B cells in vitro. J. Immunol. 154: 4936-4949.
21. + and transduces the signal for cognate activation of B cells. Proc. Natl. Acad. Sci. USA. 89: 6550-6554.
22. Iwabuchi, K., K.-I. Nakayama, R.L. McCoy, F. Wang, T. Nishimura, S. Habu, K.M. Murphy, and D.Y. Loh. 1992. Cellular and peptide requirements for in vitro clonal deletion of immature thymocytes. Proc. Natl. Acad. Sci. USA. 89: 9000-9004.
23. Nicoletti, I., G. Migliorati, M.C. Pagliacci, F. Grignani, and C. Riccardi. 1991. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods. 139: 271-279.
24. Lyons, A.B., K. Samuel, A. Sanderson, and A.H. Maddy. 1992. Simultaneous analysis of immunophenotype and apoptosis of murine thymocytes by single laser flow cytometry. Cytometry. 13: 809-821.
25. Boise, L.H., M. Gonzalez-Garcia, C.E. Postema, L. Ding, T. Lindsten, L.A. Turka, X. Mao, G. Nunez, and C.B. Thompson. 1993. bcl-x, a M-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell. 74: 597-608.
26. Motoyama, N., F. Wang, K.A. Roth, H. Sawa, K.-I. Nakayama, K. Nakayama, I. Negishi, S. Senju, Q. Zhang, S. Fujii, and D.Y. Loh. 1995. Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science (Wash. DC). 267: 1506-1510.
27. McConkey, D.J., P. Hartzell, S.C. Chow, S. Orrenius, and M. Jondal. 1990. Interleukin 1 inhibits T cell receptor-medi-ated apoptosis in immature thymocytes. J. Biol. Chem. 265: 3009-3011.
28. Groux, H., D. Monte, B. Plouvier, A. Capron, and J.C. Ameisen. 1993. CD3-mediated apoptosis of human medullary thymocytes and activated peripheral T cells: respective roles of interleukin-1, interleukin-2, interferon-"/ and accessory cells. Eur.J. Immunol. 23: 1623-1629.
29. Femandez-Ruiz, E., A. Rebollo, M.A. Nieto, E. Sanz, C. Somoza, F. Ramirez, A. Lopez-Rivas, and A. Silva. 1990. IL-2 protects T cell hybrids from the cytolytic effect of glucocorticoids: synergistic effect of IL-2 and dexamethasone in the induction of high-affinity IL-2 receptor. J. Immunol. 143: 4146-4151.
30. Nieto, M.A., and A. Lopez-Rivas. 1989. IL-2 protects T lymphocytes from glucocorticoid-induced DNA fragmentation and cell death. J. Immunol. 143: 4166-4170.
31. Nieto, M.A., A. Gonzalez, A. Lopez-Rivas, F. Diaz-Espada, and F. Gambon. 1990. IL-2 protects against anti-CD3-in-duced cell death in human medullary thymocytes. J. Immunol. 145: 1364-1368.
32. Zubiaga, A.M., E. Munoz, and B.T. Huber. 1992. IL-4 and IL-2 selectively rescue Th cell subsets from glucocorticoid-induced apoptosis. J. Immunol. 149: 107-112.
33. Dancescu, M., M. Rubio-Trujillo, G. Biron, D. Bron, G. Delespesse, and M. Sarfati. 1992. Interleukin 4 protects chronic lymphocytic leukemic B cells from death by apoptosis and upregulates Bcl-2 expression. J. Exp. Med. 176: 1319-1326.
34. Migliorati, G., I. Nicoletti, M.C. Pagliacci, L. D’Adamio, and C. Riccardi. 1993. Interleukin-4 protects double-negative and CD4 single-positive thymocytes from dexametha-sone-induced apoptosis. Blood. 81: 1352-1358.
35. Buschle, M., D. Campana, S.R. Carding, C. Richard, A.V. Hoffbrand, and M.K. Brenner. 1993. Interferon γ inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. J. Exp. Med. 177: 213-218.
36. Fluckiger, A.C., I. Durand, and J. Banchereau. 1994. Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells. J. Exp. Med. 179: 91-99.
37. Gregory, C.D., C. Dive, S. Henderson, C.A. Smith, G.T. Williams, J. Gordon, and A.B. Rickinson. 1991. Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature (Lond.). 349: 612-614.
38. +. Eur.J. Immunol. 22: 3141-3148.
39. +. Nature (Lond.). 364: 645-648.
40. +. Nature (Lond.). 357: 80-82.
41. Liu, Y.-J., G.D. Johnson, J. Gordon, and C.M. MacLennan. 1992. Germinal centres in T-cell-dependent antibody re re sponses. Immunol. Today. 13: 17-21.
42. Weissman, I.L. 1994. Developmental switches in the immune system. Cell. 76: 207-218.
43. Hockenbery, D.M., Z.N. Oltvai, X.M. Yin, C.L. Malliman, and S.J. Korsmeyer. 1993. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 75: 241-251.
44. Kane, D.J., T.A. Sarafian, R. Anton, H. Hahn, E.B. Gralla, J. Selverstone, T. Ord, and D.E. Bredesen. 1993. Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. Science (Wash. DC). 262: 1274-1277.
45. Sprent, J., M. Schaefer, M. Hurd, C.D. Surh, and Y. Ron. 1991. Mature murine B and T cells transferred to SCID mice can survive indefinitely and many maintain a virgin phenotype. J. Exp. Med. 174: 717-728.
46. Huesmann, M., B. Scott, P. Kisielow, and H. Von Boehmer. 1991. Kinetics and efficacy of positive selection in the thymus of normal and T cell receptor transgenic mice. Cell. 66: 533540.
47. Holder, M.J., K. Knox, and J. Gordon. 1992. Factors modifying survival pathways of germinal center B cells. Glucocorticoids and transforming growth factor-(3, but not cyclosporin A or anti-CD19, block surface immunoglobulin-mediated rescue from apoptosis. Eur.J. Immunol. 22: 2725-2728.
48. Gordon, J., M.J. Millsum, G.R. Guy, and J.A. Ledbetter. 1987. Synergistic interaction between interleukin 4 and anti-Bp50(CDw40) revealed in a novel B cell restimulation assay. Eur.J. Immunol. 17: 1535-1538.
49. + monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells. J. Exp. Med. 172: 1861-1864.
50. + stimulation provides an interferon-y-independent and IL-4-depen-dent differentiation signal directly to human B cells for IgE production. J. Immunol. 146: 1836-1842.
51. + T cell clones and IL-4 induce IgG4 and IgE switching in purified human B cells via different signaling pathways. J. Immunol. 147: 8-13.
52. + ligand in conjunction with IL-4. Immunity. 1: 179-187.
53. Fuller, K.A., O. Kanagawa, and M. Nahm. 1993. T cells within germinal centers are specific for the immunizing antigen. J. Immunol. 151: 4505-4512.
54. Kelsoe, G., and B. Zheng. 1993. Sites of B-cell activation in vivo. Curr. Opin. Immunol. 5: 418-422.
55. McDonnell, T.J., N. Deane, F.M. Platt, G. Nunez, U. Jaeger, J.P. McKeam, and S.J. Korsmeyer. 1989. bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell. 57: 79-88.
56. Nunez, G., D. Hockenbery, T.J. McDonnell, C.M. Sorensen, and S.J. Korsmeyer. 1991. Bcl-2 maintains B cell memory. Nature (Lond.). 353: 71-73.